Depression and anxiety
-
Depression and anxiety · Feb 2011
Randomized Controlled Trial Multicenter StudyResidual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse.
Many patients with major depressive disorder (MDD) who achieve full remission after antidepressant treatment still have residual depressive symptoms. In this study, we assess the type and frequency of residual symptoms and their relationship to subsequent depressive relapses after remission of major depression with fluoxetine. ⋯ The great majority of patients with remission of MDD after treatment with fluoxetine continue to experience selected residual depressive symptoms. The presence of residual symptoms is not significantly associated with an increased risk of relapse.